Ortho tri-cyclen lo and Blepharitis allergic - a phase IV clinical study of FDA data

Summary:

Blepharitis allergic is reported as a side effect among people who take Ortho tri-cyclen lo (ethinyl estradiol; norgestimate), especially for people who are female, 10-19 old, also take Accutane,.

The phase IV clinical study analyzes which people have Blepharitis allergic when taking Ortho tri-cyclen lo. It is created by eHealthMe based on reports of 1,354 people who have side effects when taking Ortho tri-cyclen lo from the FDA, and is updated regularly.

What is Ortho tri-cyclen lo?

Ortho tri-cyclen lo has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 1,787 Ortho tri-cyclen lo users. Check the latest studies of Ortho tri-cyclen lo.

What is Blepharitis allergic?

Blepharitis allergic (chronic inflammation of the eyelid due to an allergy) is found to be associated with 11 drugs and 13 conditions by eHealthMe. Check the latest studies of Blepharitis allergic.

On Jul, 13, 2026

1,354 people reported to have side effects when taking Ortho tri-cyclen lo.
Among them, 11 people (0.81%) have Blepharitis allergic.

Could Ortho tri-cyclen lo cause Blepharitis allergic?

Among these 11 people:

What is the gender of people who have Blepharitis allergic when taking Ortho tri-cyclen lo? *

female: 100 %
male: 0.0 %

What is the age of people who have Blepharitis allergic when taking Ortho tri-cyclen lo? *

What are other drugs people take besides Ortho tri-cyclen lo? *

Accutane: 11 people, 100.00%

What are other side effects people have besides Blepharitis allergic? *

Acquired Oesophageal Web (structural abnormalities in the oesophagus): 11 people, 100.00%
Colitis (inflammation of colon): 11 people, 100.00%
Cellulitis (infection under the skin): 11 people, 100.00%
Gastritis (inflammation of stomach): 11 people, 100.00%
Haemorrhage (bleeding): 11 people, 100.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 11 people, 100.00%
Hair Loss: 11 people, 100.00%
Headache (pain in head): 11 people, 100.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 11 people, 100.00%
Upper Respiratory Tract Infection: 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ortho tri-cyclen lo and have Blepharitis allergic?

- Check whether Blepharitis allergic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ortho tri-cyclen lo:

Ortho tri-cyclen lo (1,787 reports)

Blepharitis allergic treatments and more:

Blepharitis allergic (60 reports)

How severe was Blepharitis allergic and when was it recovered:

Blepharitis allergic in Ortho tri-cyclen lo

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestimate:

Blepharitis allergic and drugs with ingredients of ethinyl estradiol; norgestimate (11 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ortho tri-cyclen lo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blepharitis allergic:

Blepharitis allergic (11 drugs)

Browse all the conditions that are associated with Blepharitis allergic:

Blepharitis allergic (13 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Ortho tri-cyclen lo) and Ortho tri-cyclen lo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.